SSY GROUP (02005) has obtained the drug production registration certificate for the sodium bicarbonate injection solution in ampoules (10ml: 0.84g) related to the State Food and Drug Administration.

SSY GROUP (02005) announced that the group has obtained the drug production registration certificate for sodium hydrogen carbonate injection in ampoule packaging (10ml: 0.84g) from the China National Medical Products Administration. This drug belongs to the category 3 of chemical drugs and is considered to have passed consistency evaluation. Sodium hydrogen carbonate injection in ampoule packaging is mainly used to treat metabolic acidosis, alkalinization of urine, and intravenous infusion for poisoning by certain drugs.